Cyramza (Ramucirumab)

Cyramza (ramucirumab) is an intravenous medication used to treat certain types of cancer. This targeted therapy is designed to inhibit angiogenesis, the process of new blood vessel formation in tumors.

Cyramza is primarily used in combination with other cancer treatments for advanced or metastatic cancers. It is often prescribed for gastric or gastro-esophageal junction adenocarcinoma, non-small cell lung cancer, and colorectal cancer. The medication works by targeting specific proteins involved in tumor growth and blood vessel formation. Patients may wonder, 'What is Cyramza used for?'—it is generally used to slow the progression of cancer and improve survival rates in specific cases.

Common effects of Cyramza may include fatigue, hypertension, and diarrhea. Some patients may experience appetite loss, nausea, or constipation. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized information.

Cyramza should be administered under the supervision of a healthcare professional. It is important to discuss any pre-existing conditions, such as hypertension or bleeding disorders, with your doctor before starting treatment. Regular monitoring may be required to manage potential side effects.

Cyramza may interact with other medications, including those that affect blood clotting or blood pressure. It is crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.